Future work should aim to resolve whether PD risk genes including LRRK2 differentially affect specific dopamine neuron subtypes, and how LRRK2 function in dopaminergic neuron differs from other neuromodulatory projection neurons. The gene discussed is LRRK2; the disease is Parkinson disease.